“Early detection and intervention are the keys to impacting outcomes in pulmonary fibrosis, COPD, and other lung diseases,” said Dr. Lida Hariri, associate professor of pathology at Harvard Medical School and Massachusetts General Hospital, during our 2025 Annual Member Meeting. 

Dr. Hariri discussed her work with optical coherence tomography and the different ways she’s been using this minimally invasive technology to help support early diagnosis and monitoring in ILDs.